Research Paper Volume 14, Issue 23 pp 9550—9578
Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
Figure 2. Box-plots exploring the relationship between ZSCAN20 expression and clinicopathological characteristics (UALCAN). Increased ZSCAN20 expression was significantly with (A) sample type, (B) gender, (C) age, (D) cancer stage, (E) tumor grade, (F) nodal metastasis status. (G) histological subtype *P < 0.05; **P < 0.01; ***P < 0.001.